Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Corpechot, Christophe" or (type exact bookEditor and editor="Corpechot, Christophe")

Add to list
- Journal Article
- A1
- open access
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne C de Veer, Maria C van Hooff, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry L A Janssen, Pier M Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2023) AMERICAN JOURNAL OF GASTROENTEROLOGY. 118(7). p.1196-1203
Add to list
- Journal Article
- A1
- open access
Optimizing therapy in primary biliary cholangitis : alkaline phosphatase at six months identifies one-year non-responders and predicts survival

C Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, Palak J Trivedi, Christophe Corpechot, Adriaan J van der Meer, Willem J Lammers, Pier Maria Battezzati, Keith D Lindor, Frederik Nevens, et al.

(2023) LIVER INTERNATIONAL. 43(7). p.1497-1506
Add to list
- Journal Article
- A1
- open access
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis : ENHANCE, a phase 3, randomized, placebo-controlled study

Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, et al.

(2023) HEPATOLOGY. 78(2). p.397-415
Add to list
- Conference Paper
- C3
Early identification of insufficient biochemical response to ursodeoxycholic acid in patients with primary biliary cholangitis

Carla Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, Palak Trivedi, Christophe Corpechot, Adriaan J. Van der Meer, Willem J. Lammers, Pier Maria Battezzati, Keith D. Lindor, Frederik Nevens, et al.

(2021) HEPATOLOGY. In Hepatology 74(Supplement 1). p.759A-760A
Add to list
- Journal Article
- A1
Measurement of gamma glutamyl transferase to determine risk of liver transplantation or death in patients with primary biliary cholangitis

Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, Willem J. Lammers, Henk Van Buuren, Gideon Hirschfield, Harry Janssen, Christophe Corpechot, Anna Reig, Albert Pares, et al.

(2021) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 19(8). p.1688-1697
Add to list
- Conference Paper
- C3
Patients with primary biliary cholangitis treated with long-term obeticholic acid in a trial-setting demonstrate better transplant-free survival than external controls from the global PBC and UK-PBC study groups

Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Femi Adekunle, Martin Bonacci, Tracy Mayne, Elizabeth Smoot Malecha, Erik Ness, Adriaan J. Van der Meer, Willem Lammers, et al.

(2021) HEPATOLOGY. In Hepatology 74(6). p.1389A-1390A
Add to list
- Journal Article
- A1
- open access
Factors associated with progression and outcomes of early stage primary biliary cholangitis

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry LA Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-692
Add to list
- Journal Article
- A1
Goals of treatment for improved survival in primary biliary cholangitis : treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase

Carla F. Murillo Perez, Maren H. Harms, Keith D. Lindor, Henk R. van Buuren, Gideon M. Hirschfield, Christophe Corpechot, Adriaan J. van der Meer, Jordan J. Feld, Aliya Gulamhusein, Willem J. Lammers, et al.

(2020) AMERICAN JOURNAL OF GASTROENTEROLOGY. 115(7). p.1066-1074
Add to list
- Conference Paper
- C3
Characterising normal patterns of alanine aminotransferase elevations in ursodeoxycholic acid-treated patients with primary biliary cholangitis

Antoine Sioufi, Carla Fiorella Murillo Perez, Frederik Nevens, Aliya F. Gulamhusein, Marco Carbone, Palak Trivedi, Adriaan J. Van der Meer, Christophe Corpechot, Pier M. Battezzati, Willem J. Lammers, et al.

(2020) HEPATOLOGY. In Hepatology 72(Supplement 1). p.739A-740A
Add to list
- Journal Article
- A1
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis

Christophe Corpechot, Olivier Chazouilleres, Pierre Belnou, Aldo J. Montano-Loza, Andrew Mason, Maryam Ebadi, Dennis Eurich, Sascha Chopra, Dietmar Jacob, Christoph Schramm, et al.

(2020) JOURNAL OF HEPATOLOGY. 73(3). p.559-565
Add to list
- Conference Paper
- C3
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Rozanne de Veer, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Add to list
- Journal Article
- A1
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Carla F. Murillo Perez, Gideon M. Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J. Mayo, Adriaan van der Meer, Cyriel Y. Ponsioen, Willem J. Lammers, Albert Pares, Pietro Invernizzi, et al.

(2019) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50(10). p.1127-1136
Add to list
- Conference Paper
- C3
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne de Veer, Maren H Harms, Jorn Goet, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.776A-777A
Add to list
- Conference Paper
- C3
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Carla Fiorella Murillo Perez, Willem J Lammers, Annarosa Floreani, Christophe Corpechot, Adriaan Van der Meer, Aliya Gulamhusein, Cyriel Ponsioen, Marco Carbone, Marlyn J Mayo, Pietro Invernizzi, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.793A-794A
Add to list
- Conference Paper
- C3
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Jorn Goet, Surain Roberts, Gideon Hirschfield, Pietro Invernizzi, Marco Carbone, Palak Trivedi, Christophe Corpechot, Harry LA Janssen, Rozanne de Veer, Willem J Lammers, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.760A-761A
Add to list
- Journal Article
- A1
Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival

Aldo J. Montano-Loza, Bettina E. Hansen, Christophe Corpechot, Davide Roccarina, Douglas Thorburn, Palak Trivedi, Gideon Hirschfield, Patrick McDowell, Raoul Poupon, Jerome Dumortier, et al.

(2019) GASTROENTEROLOGY. 156(1). p.96-107
Add to list
- Journal Article
- A1
Effects of age and sex of response to ursodeoxycholic arid and transplant-free survival in patients with primary biliary cholangitis

Angela C. Cheung, Willem J. Lammers, Carla F. Murillo Perez, Henk R. van Buuren, Aliya Gulamhusein, Palak J. Trivedi, Konstantinos N. Lazaridis, Cyriel Y. Ponsioen, Annarosa Floreani, Gideon M. Hirschfield, et al.

(2019) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 17(10). p.2076-2084.e2
Add to list
- Journal Article
- A1
Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry LA Janssen, Pier M Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2018) AMERICAN JOURNAL OF GASTROENTEROLOGY. 113(2). p.254-264
Add to list
- Journal Article
- A1
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Fiorella Murillo Perez, Jorn C Goet, Willem J Lammers, Aliya Gulamhusein, Henk R van Buuren, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY. 67(5). p.1920-1930
Add to list
- Conference Paper
- C3
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Carla Fiorella Murillo Perez, Aliya Gulamhusein, Christophe Corpechot, Adriaan Van der Meer, Henk R Van Buuren, Pietro Invernizzi, Palak Trivedi, Frederik Nevens, Marlyn J Mayo, Pier Maria Battezzati, et al.

(2018) HEPATOLOGY. 68(suppl. 1). p.1085A-1086A

Academic Bibliography

Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Optimizing therapy in primary biliary cholangitis : alkaline phosphatase at six months identifies one-year non-responders and predicts survival

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis : ENHANCE, a phase 3, randomized, placebo-controlled study

Early identification of insufficient biochemical response to ursodeoxycholic acid in patients with primary biliary cholangitis

Measurement of gamma glutamyl transferase to determine risk of liver transplantation or death in patients with primary biliary cholangitis

Patients with primary biliary cholangitis treated with long-term obeticholic acid in a trial-setting demonstrate better transplant-free survival than external controls from the global PBC and UK-PBC study groups

Factors associated with progression and outcomes of early stage primary biliary cholangitis

Goals of treatment for improved survival in primary biliary cholangitis : treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase

Characterising normal patterns of alanine aminotransferase elevations in ursodeoxycholic acid-treated patients with primary biliary cholangitis

Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies

Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival

Effects of age and sex of response to ursodeoxycholic arid and transplant-free survival in patients with primary biliary cholangitis

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome

Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Contents

Support

Contact